Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR)

被引:98
作者
Chao, Elizabeth C. [1 ]
Velasquez, Jonathan L. [1 ]
Witherspoon, Mavee S. L. [1 ]
Rozek, Laura S. [2 ]
Peel, David [1 ]
Ng, Pauline [3 ]
Gruber, Stephen B. [2 ]
Watson, Patrice [4 ]
Rennert, Gad [5 ,6 ,7 ]
Anton-Culver, Hoda [1 ]
Lynch, Henry [4 ]
Lipkin, Steven M. [1 ]
机构
[1] Univ Calif Irvine, Canc Genet Clin, Div Hematol Oncol, Genet Epidemiol Res Inst, Irvine, CA 92697 USA
[2] Univ Michigan, Dept Internal Med Epidemiol & Human Genet, Ann Arbor, MI 48109 USA
[3] J Craig Venter Inst Human Genet, Rockville, MD USA
[4] Creighton Univ, Sch Med, Hereditary Canc Inst, Omaha, NE USA
[5] Carmel Hosp, Dept Community Med & Epidemiol, Haifa, Israel
[6] Techn Faculty Med, Haifa, Israel
[7] CHS Natl Canc Control Ctr, Haifa, Israel
关键词
Lynch syndrome; colorectal cancer; variants of uncertain significance; cancer genetics; HNPCC; MLH1; MSH;
D O I
10.1002/humu.20735
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Lynch syndrome, also known as hereditary nonpolyposis colon cancer (HNPCC), is the most common known genetic syndrome for colorectal cancer (CRC). MLH1/MSH2 mutations underlie approximately 90% of Lynch syndrome families. A total of 24% of these mutations are missense. Interpreting missense variation is extremely challenging. We have therefore developed multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR), a bioinformatic algorithm that effectively classifies MLH1/MSH2 deleterious and neutral missense variants. We compiled a large database (n>300) of MLH1/MSH2 missense variants with associated clinical and molecular characteristics. We divided this database into nonoverlapping training and validation sets and tested MAPP-MMR. MAPP-MMR significantly outperformed other missense variant classification algorithms (sensitivity, 94%; specificity, 96%; positive predictive value [PPV] 98%; negative predictive value [NPV], 89%), such as SIFT and PolyPhen. MAPP-MMR is an effective bioinformatic tool for missense variant interpretation that accurately distinguishes MLH1/MSH2 deleterious variants from neutral variants.
引用
收藏
页码:852 / 860
页数:9
相关论文
共 58 条
  • [1] Anton-Culver Hoda, 2003, Community Genet, V6, P171, DOI 10.1159/000078165
  • [2] Prediction of MLH1 and MSH2 mutations in Lynch syndrome
    Balmana, Judith
    Stockwell, David H.
    Steyerberg, Ewout W.
    Stoffel, Elena M.
    Deffenbaugh, Amie M.
    Reid, Julia E.
    Ward, Brian
    Scholl, Thomas
    Hendrickson, Brant
    Tazelaar, John
    Burbidge, Lynn Anne
    Syngal, Sapna
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (12): : 1469 - 1478
  • [3] Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer
    Barnetson, Rebecca A.
    Tenesa, Albert
    Farrington, Susan M.
    Nicholl, Iain D.
    Cetnarskyj, Roseanne
    Porteous, Mary E.
    Campbell, Harry
    Dunlop, Malcolm G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (26) : 2751 - 2763
  • [4] Study design: Evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study
    Bernstein, JL
    Langholz, B
    Haile, RW
    Bernstein, L
    Thomas, DC
    Stovall, M
    Malone, KE
    Lynch, CF
    Olsen, JH
    Anton-Culver, H
    Shore, RE
    Boice, JD
    Berkowitz, GS
    Gatti, RA
    Teitelbaum, SL
    Smith, SA
    Rosenstein, BS
    Borresen-Dale, AL
    Concannon, P
    [J]. BREAST CANCER RESEARCH, 2004, 6 (03): : R199 - R214
  • [5] A human cell-based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene
    Blasi, Monica Francesca
    Ventura, Ilenia
    Aquilina, Gabriele
    Degan, Paolo
    Bertario, Lucio
    Bassi, Chiara
    Radice, Paolo
    Bignami, Margherita
    [J]. CANCER RESEARCH, 2006, 66 (18) : 9036 - 9044
  • [6] Burt R W, 1997, Gastrointest Endosc Clin N Am, V7, P65
  • [7] BURT RW, 1996, PREVENTION EARLY DET
  • [8] Interpreting missense variants:: Comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR)
    Chan, Philip A.
    Duraisamy, Sekhar
    Miller, Peter J.
    Newell, Joan A.
    McBride, Carole
    Bond, Jeffrey P.
    Raevaara, Tiina
    Ollila, Saara
    Nystrom, Minna
    Grimm, Andrew J.
    Christodoulou, John
    Oetting, William S.
    Greenblatt, Marc S.
    [J]. HUMAN MUTATION, 2007, 28 (07) : 683 - 693
  • [9] Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: Structure-based assessment of amino acid variation
    Chasman, D
    Adams, RM
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2001, 307 (02) : 683 - 706
  • [10] Prediction of germline mutations and cancer risk in the Lynch syndrome
    Chen, Sining
    Wang, Wenyi
    Lee, Shing
    Nafa, Khedoudja
    Lee, Johanna
    Romans, Kathy
    Watson, Patrice
    Gruber, Stephen B.
    Euhus, David
    Kinzler, Kenneth W.
    Jass, Jeremy
    Gallinger, Steven
    Lindor, Noralane M.
    Casey, Graham
    Ellis, Nathan
    Giardiello, Francis M.
    Offit, Kenneth
    Parmigiani, Giovanni
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (12): : 1479 - 1487